Paola Santoro currently serves as the Vice President of Clinical Development and Operations at AdvanCell, a role assumed in January 2025. Prior to this position, Paola was the Clinical Trial Director at Ariceum Therapeutics, where leadership was demonstrated in phase I and phase II trials, specifically in small cell lung cancer and Merkel cell carcinoma. Previous experience includes serving as Global Trial Director at Novartis, overseeing pivotal trials for the marketing authorization of Lutathera, and as Associate Director of Clinical Development at Advanced Accelerator Applications, contributing significantly to oncology studies. Early career roles included project management in various therapeutic areas at Phidea Marvin and OPIS s.r.l. Paola holds a Master of Science in Biology from Università degli Studi di Milano and has completed a Project Management course at SDA Bocconi.
This person is not in any teams
This person is not in any offices